CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Dynavax Technologies Corporation - DVAX CFD

12.38
0%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 0.07
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Dynavax Technologies Corp ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 12.38
Open* 12.34
1-Year Change* 24.65%
Day's Range* 12.31 - 12.46
52 wk Range 9.42-15.15
Average Volume (10 days) 2.24M
Average Volume (3 months) 34.75M
Market Cap 1.81B
P/E Ratio 37.85
Shares Outstanding 129.26M
Revenue 361.18M
EPS 0.37
Dividend (Yield %) N/A
Beta 1.26
Next Earnings Date Feb 21, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 28, 2024 12.38 0.07 0.57% 12.31 12.48 12.30
Mar 27, 2024 12.38 0.00 0.00% 12.38 12.42 12.30
Mar 26, 2024 12.34 -0.11 -0.88% 12.45 12.56 12.32
Mar 25, 2024 12.47 0.43 3.57% 12.04 12.50 12.04
Mar 22, 2024 12.26 0.24 2.00% 12.02 12.33 11.96
Mar 21, 2024 12.14 -0.01 -0.08% 12.15 12.35 12.11
Mar 20, 2024 12.07 0.19 1.60% 11.88 12.11 11.87
Mar 19, 2024 11.99 0.53 4.62% 11.46 12.03 11.46
Mar 18, 2024 11.67 -0.20 -1.68% 11.87 11.97 11.61
Mar 15, 2024 12.02 0.18 1.52% 11.84 12.15 11.84
Mar 14, 2024 11.99 0.00 0.00% 11.99 12.15 11.87
Mar 13, 2024 12.14 -0.39 -3.11% 12.53 12.67 11.99
Mar 12, 2024 12.60 -0.20 -1.56% 12.80 12.89 12.60
Mar 11, 2024 12.93 -0.01 -0.08% 12.94 13.22 12.86
Mar 8, 2024 13.11 0.31 2.42% 12.80 13.22 12.80
Mar 7, 2024 12.77 0.17 1.35% 12.60 12.89 12.54
Mar 6, 2024 12.70 0.25 2.01% 12.45 12.73 12.40
Mar 5, 2024 12.52 -0.06 -0.48% 12.58 12.73 12.49
Mar 4, 2024 12.71 0.01 0.08% 12.70 12.74 12.49
Mar 1, 2024 12.73 0.07 0.55% 12.66 12.87 12.57

Dynavax Technologies Corporation Events

Time (UTC) Country Event
Tuesday, April 30, 2024

Time (UTC)

10:59

Country

US

Event

Q1 2024 Dynavax Technologies Corp Earnings Release
Q1 2024 Dynavax Technologies Corp Earnings Release

Forecast

-

Previous

-
Friday, May 24, 2024

Time (UTC)

16:00

Country

US

Event

Dynavax Technologies Corp Annual Shareholders Meeting
Dynavax Technologies Corp Annual Shareholders Meeting

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 722.683 439.442 46.551 35.219 8.198
Revenue 722.683 439.442 46.551 35.219 8.198
Total Operating Expense 439.161 310.188 114.922 170.062 161.517
Selling/General/Admin. Expenses, Total 129.185 98.25 76.96 76.815 61.978
Research & Development 46.6 32.228 28.607 62.331 74.951
Unusual Expense (Income) 1.223 6.138 -4.555 11.527 2.792
Operating Income 283.522 129.254 -68.371 -134.843 -153.319
Interest Income (Expense), Net Non-Operating 2.881 -61.29 -12.878 -21.307 -5.21
Other, Net 7.896 9.557 6.009 3.55 -0.37
Net Income Before Taxes 294.299 77.521 -75.24 -152.6 -158.899
Net Income After Taxes 293.156 76.713 -75.24 -152.6 -158.899
Net Income Before Extra. Items 293.156 76.713 -75.24 -152.6 -158.899
Net Income 293.156 76.713 -75.24 -152.6 -158.899
Income Available to Common Excl. Extra. Items 292.873 72.144 -75.24 -155.867 -158.899
Income Available to Common Incl. Extra. Items 292.873 72.144 -75.24 -155.867 -158.899
Diluted Net Income 292.873 72.144 -75.24 -155.867 -158.899
Diluted Weighted Average Shares 150.797 133.006 100.753 72.024 62.362
Diluted EPS Excluding Extraordinary Items 1.94217 0.54241 -0.74678 -2.1641 -2.54801
Diluted Normalized EPS 1.95025 0.58808 -0.79199 -2.00405 -2.50324
Other Operating Expenses, Total
Total Extraordinary Items
Cost of Revenue, Total 262.153 173.572 13.91 19.389 21.796
Gross Profit 460.53 265.87 32.641 15.83 -13.598
Total Adjustments to Net Income -0.283 -4.569 -3.267
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 60.249 46.925 184.492 167.735 256.464
Revenue 60.249 46.925 184.492 167.735 256.464
Cost of Revenue, Total 13.537 14.712 77.488 61.334 83.369
Gross Profit 46.712 32.213 107.004 106.401 173.095
Total Operating Expense 63.654 77.173 121.357 106.338 128.237
Selling/General/Admin. Expenses, Total 36.174 48.152 30.382 31.604 35.735
Research & Development 13.046 13.605 12.854 12.962 9.689
Unusual Expense (Income) 0.897 0.704 0.633 0.438 -0.556
Operating Income -3.405 -30.248 63.135 61.397 128.227
Interest Income (Expense), Net Non-Operating 5.69 4.911 2.64 0.877 -0.918
Other, Net 1.922 1.621 2.199 1.818 2.065
Net Income Before Taxes 4.207 -23.716 67.974 64.092 129.374
Net Income After Taxes 3.431 -24.332 67.733 63.809 128.755
Net Income Before Extra. Items 3.431 -24.332 67.733 63.809 128.755
Net Income 3.431 -24.332 67.733 63.809 128.755
Income Available to Common Excl. Extra. Items 3.431 -24.332 67.45 63.809 128.755
Income Available to Common Incl. Extra. Items 3.431 -24.332 67.45 63.809 128.755
Diluted Net Income 3.431 -24.332 67.45 63.809 128.755
Diluted Weighted Average Shares 152.142 127.921 151.889 151.538 149.905
Diluted EPS Excluding Extraordinary Items 0.02255 -0.19021 0.44407 0.42108 0.85891
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS 0.02736 -0.18663 0.44823 0.42395 0.85522
Total Adjustments to Net Income -0.283
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 916.985 972.52 290.015 208.653 174.364
Cash and Short Term Investments 624.395 545.95 165.036 151.055 145.536
Cash & Equivalents 202.004 436.189 32.073 39.884 49.348
Short Term Investments 422.391 109.761 132.963 111.171 96.188
Total Receivables, Net 147.515 131.816 22.661 8.886 3.704
Accounts Receivable - Trade, Net 145.13 116.216 22.661 8.886 3.704
Prepaid Expenses 85.629 233.419 38.629 7.38 6.102
Total Assets 985.85 1039.25 353.272 279.068 210.884
Property/Plant/Equipment, Total - Net 63.341 60.984 57.15 62.274 17.064
Property/Plant/Equipment, Total - Gross 90.863 86.362 80.561 80.261 40.213
Accumulated Depreciation, Total -27.522 -25.378 -23.411 -17.987 -23.149
Goodwill, Net 2.006 2.125 2.297 2.081 2.144
Other Long Term Assets, Total 3.518 3.617 3.81 3.56 5.595
Total Current Liabilities 150.074 556.402 77.411 53.047 38.033
Accounts Payable 3.211 2.6 3.312 9.278 5.278
Accrued Expenses 146.863 185.909 25.151 21.961 25.755
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 0 367.893 48.948 21.808 7
Total Liabilities 404.837 816.872 294.579 270.778 147.819
Total Long Term Debt 221.578 220.49 179.811 178.601 100.871
Other Liabilities, Total 33.185 39.98 37.357 39.13 8.915
Total Equity 581.013 222.374 58.693 8.29 63.065
Preferred Stock - Non Redeemable, Net 0 0 0 0
Common Stock 0.128 0.123 0.11 0.084 0.063
Additional Paid-In Capital 1510.52 1441.87 1352.37 1229.42 1131.24
Retained Earnings (Accumulated Deficit) -924.195 -1217.35 -1294.06 -1218.82 -1066.22
Other Equity, Total -5.438 -2.266 0.273 -2.387 -2.015
Total Liabilities & Shareholders’ Equity 985.85 1039.25 353.272 279.068 210.884
Total Common Shares Outstanding 127.604 122.945 110.19 83.871 62.862
Total Inventory 59.446 61.335 63.689 41.332 19.022
Other Current Assets, Total 0
Intangibles, Net 0 2.5 11.717
Long Term Debt 221.578 220.49 179.811 178.601 100.871
Total Preferred Shares Outstanding 0 0 0.004 0.005
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 835.666 797.46 830.141 916.985 932.944
Cash and Short Term Investments 720.416 681.525 651.956 624.395 586.486
Cash & Equivalents 154.511 226.823 174.35 202.004 198.576
Short Term Investments 565.905 454.702 477.606 422.391 387.91
Total Receivables, Net 46.866 45.353 104.866 147.515 131.118
Accounts Receivable - Trade, Net 46.347 43.245 101.738 145.13 129.772
Total Inventory 49.412 53.088 57.693 59.446 102.609
Prepaid Expenses 18.972 17.494 15.626 85.629 112.731
Total Assets 972.933 936.432 969.922 985.85 999.337
Property/Plant/Equipment, Total - Net 61.132 62.808 63.592 63.341 61.032
Goodwill, Net 1.981 2.039 2.038 2.006 1.835
Other Long Term Assets, Total 74.154 74.125 74.151 3.518 3.526
Total Current Liabilities 54.264 44.862 91.515 150.074 244.08
Accounts Payable 3.12 3.246 7.296 3.211 3.05
Accrued Expenses 51.144 41.616 84.219 146.863 153.629
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 0 87.401
Total Liabilities 368.017 359.227 406.19 404.837 498.761
Total Long Term Debt 222.415 222.134 221.855 221.578 221.303
Long Term Debt 222.415 222.134 221.855 221.578 221.303
Other Liabilities, Total 91.338 92.231 92.82 33.185 33.378
Total Equity 604.916 577.205 563.732 581.013 500.576
Preferred Stock - Non Redeemable, Net
Common Stock 0.129 0.129 0.128 0.128 0.127
Additional Paid-In Capital 1541.55 1527.54 1516.33 1510.52 1501.64
Retained Earnings (Accumulated Deficit) -930.803 -945.096 -948.527 -924.195 -991.928
Other Equity, Total -5.959 -5.372 -4.2 -5.438 -9.262
Total Liabilities & Shareholders’ Equity 972.933 936.432 969.922 985.85 999.337
Total Common Shares Outstanding 129.195 128.779 128.472 127.604 127.581
Total Preferred Shares Outstanding 0 0 0 0
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 293.156 76.713 -75.24 -152.6 -158.899
Cash From Operating Activities 62.716 335.528 -92.251 -121.252 -131.301
Cash From Operating Activities 3.812 4.296 4.273 8.938 3.621
Amortization 0 0 2.5 9.217 10.862
Non-Cash Items 64.165 82.299 9.13 46.859 24.772
Cash Interest Paid 5.638 9.815 16.541 12.147 6.583
Changes in Working Capital -298.417 172.22 -32.914 -33.666 -11.657
Cash From Investing Activities -315.995 14.225 -26.532 -42.782 55.466
Capital Expenditures -7.139 -9.477 -11.072 -29.401 -15.187
Other Investing Cash Flow Items, Total -308.856 23.702 -15.46 -13.381 70.653
Cash From Financing Activities 19.525 55.776 109.499 154.351 99.071
Financing Cash Flow Items 1.431 0.841 0.672 0.565 0.594
Issuance (Retirement) of Stock, Net 18.094 25.307 108.827 79.536 -0.523
Issuance (Retirement) of Debt, Net 0 29.628 0 74.25 99
Foreign Exchange Effects -0.443 -1.431 1.494 -0.184 -0.482
Net Change in Cash -234.197 404.098 -7.79 -9.867 22.754
Cash Taxes Paid 2.208 1.312
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -24.332 293.156 225.423 161.614 32.859
Cash From Operating Activities 27.622 62.716 27.768 -33.792 -50.443
Cash From Operating Activities 1.013 3.812 2.975 2.085 0.985
Amortization 0
Non-Cash Items 21.177 64.165 38.369 14.46 8.087
Cash Interest Paid 5.638 2.819 2.819 0
Changes in Working Capital 29.764 -298.417 -238.999 -211.951 -92.374
Cash From Investing Activities -52.334 -315.995 -283.028 -163.981 -216.483
Capital Expenditures -1.283 -7.139 -5.552 -4.271 -1.358
Other Investing Cash Flow Items, Total -51.051 -308.856 -277.476 -159.71 -215.125
Cash From Financing Activities -3.09 19.525 19.372 11.315 10.287
Financing Cash Flow Items -3.329 1.431 1.43 0.71 0.71
Issuance (Retirement) of Stock, Net 0.239 18.094 17.942 10.605 9.577
Foreign Exchange Effects 0.151 -0.443 -1.755 -0.657 -0.134
Net Change in Cash -27.651 -234.197 -237.643 -187.115 -256.773
Issuance (Retirement) of Debt, Net 0 0 0
Cash Taxes Paid 0.032 2.208 0.788 0.509 0.087

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Dynavax Technologies Corporation Company profile

Dynavax Technologies Corporation, a biopharmaceutical company, focuses on leveraging the power of the body''s innate and adaptive immune responses through toll-like receptor stimulation. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older. Its immuno-oncology portfolio includes development stage products, such as SD-101 and DV281. Dynavax Technologies Corporation has a research collaboration with Clover Biopharmaceuticals; the University of Queensland and the Coalition for Epidemic Preparedness; and Sinovac Biotech Ltd. for the development of a vaccine candidate to prevent coronavirus (COVID-19). Dynavax Technologies Corporation has partnership with the Coalition for Epidemic Preparedness Innovations (CEPI) to create a vaccine against COVID-19 infection; a collaboration with Valneva SE to initiate a vaccine program for the coronavirus, COVID-19; and collaboration with Medicago to develop a novel adjuvanted COVID 19 vaccine candidate. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was founded in 1996 and is headquartered in Emeryville, California.
Industry: Bio Therapeutic Drugs

2100 Powell Street
Suite 720
EMERYVILLE
CALIFORNIA 94608
US

Income Statement

  • Annual
  • Quarterly

News

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

Higher CPI leaves traders unfazed as US equities continue to build momentum

The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.

12:42, 15 March 2024

Four reasons why Bitcoin is surging to record highs

Bitcoin has surged to record highs. We discuss the four factors pushing Bitcoin higher and analyse the technicals of the cryptocurrency’s technicals.

10:18, 14 March 2024

China’s National People’s Congress: The markets have again been left wanting more

China’s National People’s Congress (NPC) is underway, and the markets have so far been disappointed by what’s been delivered by the country’s central government. We look at some of the significant takeaways from the event, discuss China’s current economic conditions, and analyse the China A50.

08:23, 8 March 2024
Facade on the Federal Reserve Building in Washington DC

Central Banks: which one will cut first?

Central banks dominate the calendar in March and markets try to anticipate which one will be the first one to cut

13:14, 6 March 2024

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

People also watch

BTC/USD

70,404.15 Price
-0.410% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

US100

18,249.40 Price
-0.200% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 7.0

Gold

2,233.43 Price
+1.740% 1D Chg, %
Long position overnight fee -0.0188%
Short position overnight fee 0.0106%
Overnight fee time 21:00 (UTC)
Spread 0.80

XRP/USD

0.64 Price
+1.850% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading